Recommended Topic Related To:
Inomax
FDA Approves Breo Ellipta to Treat COPD »
"The U.S. Food and Drug Administration today approved Breo Ellipta (fluticasone furoate and vilanterol inhalation powder) for the long-term, once-daily, maintenance treatment of airflow obstruction in patients with chronic obstructive pulmonary di"...
Inomax
PATIENT INFORMATION
No information provided. Please refer to the WARNINGS AND PRECAUTIONS section.
Last reviewed on RxList: 3/20/2013
This monograph has been modified to include the generic and brand name in many instances.
Next: Drug Description
Additional Inomax Information
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Women's Health
Find out what women really need.
Updated & New
